BeiGene USA

BeiGene USA is owned by BeiGene.

BeiGene is one of the...

• Forbes Global 2000 (#1783).

BeiGene is a company listed under the stock ticker 6160 (HK).

BeiGene has a direct presence in 2 countries.

They are in:

• Biotechnology67%
• Pharmaceuticals33%

View the org chart displaying its 11 main executives

Most searched biographies at BeiGene USA

• Linda Marchese, Vice President, Global Total Rewards
• Mark Riedl, Vice President, Sales
• Clare Fisher, Senior Vice President, Business Development and M&A

Popular executive movements at BeiGene

• Thomas Malley, Non-Executive Independent Director, has left the company  (posted on January 24 2024).
• Olivier Brandicour has joined the company as Director  (posted on January 24 2024).

Create your alert
to follow the executive moves at BeiGene USA.

BeiGene has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by BeiGene USA

Social media about BeiGene USA

• BeiGene USA on Wikipedia, Google News & Yahoo Finance
• BeiGene USA on LinkedIn, Twitter & YouTube

Contact by email its executives including Javad Shahidi

Call BeiGene USA at +1 781...

View the org chart

Register to receive your alert

Report an error